PPIB and cardiovascular disorder: The substantial evidence supporting the beneficial role of oat β-glucans has prompted the US FDA to authorize health claims on oat products, attributing the reduction in cardiovascular disease risk to consuming at least 3 g per day of β-glucan [68].